Wai Chun Bio-Technology Limited (0660.HK)
HKD 0.08
(-8.43%)
HKD 0.08
(-8.43%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 229.69 Million HKD | -5.83% |
| 2021 | 243.91 Million HKD | 21.18% |
| 2020 | 201.29 Million HKD | -5.36% |
| 2019 | 212.68 Million HKD | 10.77% |
| 2018 | 192.01 Million HKD | 7.02% |
| 2017 | 179.42 Million HKD | 12.22% |
| 2016 | 159.88 Million HKD | -4.79% |
| 2015 | 167.91 Million HKD | 27.22% |
| 2014 | 131.99 Million HKD | -25.94% |
| 2013 | 178.21 Million HKD | -50.53% |
| 2012 | 360.24 Million HKD | 91.71% |
| 2011 | 187.91 Million HKD | -30.11% |
| 2010 | 268.85 Million HKD | 110.86% |
| 2009 | 127.5 Million HKD | -21.57% |
| 2008 | 162.56 Million HKD | 147.01% |
| 2007 | 65.81 Million HKD | 24.1% |
| 2006 | 53.02 Million HKD | -26.93% |
| 2005 | 72.57 Million HKD | 1.24% |
| 2004 | 71.69 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 253.51 Million HKD | 0.0% |
| 2023 Q3 | 253.51 Million HKD | 10.37% |
| 2023 Q2 | 229.69 Million HKD | 0.0% |
| 2023 Q1 | 229.69 Million HKD | -19.54% |
| 2022 Q2 | 243.91 Million HKD | 0.0% |
| 2022 FY | 229.69 Million HKD | -5.83% |
| 2022 Q3 | 285.45 Million HKD | 17.03% |
| 2022 Q4 | 285.45 Million HKD | 0.0% |
| 2021 Q2 | 218.23 Million HKD | 0.0% |
| 2021 Q1 | 218.23 Million HKD | 8.42% |
| 2021 Q3 | 210.11 Million HKD | -3.72% |
| 2021 Q4 | 210.11 Million HKD | 0.0% |
| 2021 FY | 243.91 Million HKD | 21.18% |
| 2020 FY | 201.29 Million HKD | -5.36% |
| 2020 Q1 | 218.08 Million HKD | 2.54% |
| 2020 Q2 | 218.08 Million HKD | 0.0% |
| 2020 Q3 | 201.29 Million HKD | -7.7% |
| 2020 Q4 | 201.29 Million HKD | 0.0% |
| 2019 Q1 | 211.15 Million HKD | 9.96% |
| 2019 Q4 | 212.68 Million HKD | 0.0% |
| 2019 Q3 | 212.68 Million HKD | 0.73% |
| 2019 Q2 | 211.15 Million HKD | 0.0% |
| 2019 FY | 212.68 Million HKD | 10.77% |
| 2018 Q2 | 191.09 Million HKD | 0.0% |
| 2018 FY | 192.01 Million HKD | 7.02% |
| 2018 Q4 | 192.01 Million HKD | 0.0% |
| 2018 Q3 | 192.01 Million HKD | 0.48% |
| 2018 Q1 | 191.09 Million HKD | 6.51% |
| 2017 Q2 | 185.44 Million HKD | 0.0% |
| 2017 FY | 179.42 Million HKD | 12.22% |
| 2017 Q3 | 179.42 Million HKD | -3.24% |
| 2017 Q4 | 179.42 Million HKD | 0.0% |
| 2017 Q1 | 185.44 Million HKD | 15.99% |
| 2016 Q4 | 159.88 Million HKD | 0.0% |
| 2016 Q1 | 173.85 Million HKD | 3.54% |
| 2016 Q2 | 173.85 Million HKD | 0.0% |
| 2016 FY | 159.88 Million HKD | -4.79% |
| 2016 Q3 | 159.88 Million HKD | -8.04% |
| 2015 Q3 | 167.91 Million HKD | 0.44% |
| 2015 Q2 | 167.18 Million HKD | 0.0% |
| 2015 Q1 | 167.18 Million HKD | 26.66% |
| 2015 FY | 167.91 Million HKD | 27.22% |
| 2015 Q4 | 167.91 Million HKD | 0.0% |
| 2014 Q1 | 150.8 Million HKD | -15.38% |
| 2014 FY | 131.99 Million HKD | -25.94% |
| 2014 Q4 | 131.99 Million HKD | 0.0% |
| 2014 Q3 | 131.99 Million HKD | -12.47% |
| 2014 Q2 | 150.8 Million HKD | 0.0% |
| 2013 Q2 | 330.31 Million HKD | 0.0% |
| 2013 Q3 | 178.21 Million HKD | -46.05% |
| 2013 Q4 | 178.21 Million HKD | 0.0% |
| 2013 FY | 178.21 Million HKD | -50.53% |
| 2013 Q1 | 330.31 Million HKD | -8.31% |
| 2012 FY | 360.24 Million HKD | 91.71% |
| 2012 Q4 | 360.24 Million HKD | 0.0% |
| 2012 Q2 | 204.55 Million HKD | 0.0% |
| 2011 FY | 187.91 Million HKD | -30.11% |
| 2011 Q4 | 187.91 Million HKD | 0.0% |
| 2011 Q2 | 263.34 Million HKD | 0.0% |
| 2010 FY | 268.85 Million HKD | 110.86% |
| 2010 Q2 | 102.39 Million HKD | 0.0% |
| 2010 Q4 | 268.85 Million HKD | 0.0% |
| 2009 FY | 127.5 Million HKD | -21.57% |
| 2009 Q4 | 127.5 Million HKD | 0.0% |
| 2008 FY | 162.56 Million HKD | 147.01% |
| 2007 FY | 65.81 Million HKD | 24.1% |
| 2006 FY | 53.02 Million HKD | -26.93% |
| 2005 FY | 72.57 Million HKD | 1.24% |
| 2004 FY | 71.69 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Lee & Man Chemical Company Limited | 1.22 Billion HKD | 81.314% |